(Q46028678)
Statements
Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction (English)
Y Kitamura
I Spigelman
Y Yamamoto
W Sonoyama
H Kamioka
T Yamashiro